Sekhmet Pharmaventures Private Limited, a active private limited company, was established on 23 June 2020 in Mumbai, Maharashtra, India. Engaging in api manufacturers within the professional, scientific and technical sector, it holds CIN: U74999MH2020PTC340954. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹3,250.00 Cr and a paid-up capital of ₹2,133.52 Cr.
Formerly known as Stepahead Business Services Private Limited. It upholds a compliant status. Employing 12 professional, Its leadership includes Aswin Vikram (Director), Vivek Chhachhi (Director), Anchit Gupta (Director). Past directors included Srinivasareddy Desireddy, Ashwin Savio Trinidad, Lincoln Lin Feng Pan. Its latest AGM occurred on 31 January 2025, with the balance sheet filed on 31 March 2024. It is based at Unit No. 220, C-Wing, 2Nd Floor, 215 Atrium Cts,, Andheri Kurla Road, Andheri East, Mumbai, Maharashtra, 400059.
U74999MH2020PTC340954
340954
23 June 2020
₹3,250.00 Cr
₹2,133.52 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Sekhmet Pharmaventures Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Aswin Vikram | Director | 28 Oct 2022 | Current |
| Vivek Chhachhi | Director | 04 Dec 2020 | Current |
| Anchit Gupta | Director | 04 Dec 2020 | Current |
| Nikhilkumar Srivastava | Director | 03 Oct 2020 | Current |
| Santosh Kumar Mahil | Ceo | 03 Jun 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 25 Dec 2023 | Past |
| Pramod Abcsdd | Company Secretary | 30 Apr 2024 | Past |
| Pramod Abcsdd | Director | 17 Jun 2022 | Past |
| Pramod Abcsdd | Additional Director | 25 Dec 2023 | Past |
| Pramod Abcsdd | Additional Director | 20 Jun 2023 | Past |
| Pramod Abcsdd | Additional Director | 01 Apr 2025 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sekhmet Pharmaventures Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 166.83% increase. The company also saw a substantial fall in profitability, with a 90.82% decrease in profit. The company's net worth Soared by an impressive increase of 11006.22%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Sekhmet Pharmaventures had a promoter holding of 100.00%. The company had 4 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Sekhmet Pharmaventures has a workforce of 12 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Sekhmet Pharmaventures, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sekhmet Pharmaventures's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Santosh Kumar Mahil was appointed as a Ceo was appointed as a Ceo on 16 Jun 2025 & has been associated with this company since 5 months 18 days . was completed.
Progress on Santosh Kumar Mahil was appointed as a CEO was appointed as a CEO on 03 Jun 2025 & has been associated with this company since 6 months 1 day . was documented.
The activity Sekhmet Pharmaventures Private Limited last Annual general meeting of members was held on 31 Jan 2025 as per latest MCA records. was completed.
The activity Swati Shukla was appointed as a Company Secretary was appointed as a Company Secretary on 04 Nov 2024 & has been associated with this company since 1 year 28 days . was completed.
The activity Sekhmet Pharmaventures Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
The activity Aswin Vikram was appointed as a Director was appointed as a Director on 28 Oct 2022 & has been associated with this company since 3 years 1 month . was completed.
The bid came in late last week after the company extended the deadline a second time.
Nirma, known for its eponymous washing detergent brand, have entered the final round of bidding for a stake of about 83% in the Mumbai-listed company held by Glenmark Pharmaceuticals Ltd which has a portfolio of 139 molecules and supplies its products to customers in India and abroad including Europe and North America. The company has four plants in India..
Khubchandani, in his most recent role, has served as Co-CEO and Whole-time Director of Jubilant Ingrevia. Over his 20-year career at Jubilant Ingrevia, Khubchandani was a strategic business leader, developed high-performing teams, and oversaw solutions and offerings for pharmaceutical, agrochemical, and industrial clients..
The CIN of Sekhmet Pharmaventures Private Limited is U74999MH2020PTC340954.
Sekhmet Pharmaventures Private Limited is headquartered at Unit No. 220, C-Wing, 2Nd Floor, 215 Atrium Cts,, Andheri Kurla Road, Andheri East, Mumbai, Maharashtra, 400059.
Sekhmet Pharmaventures Private Limited was incorporated on 23 June 2020.
The current directors of Sekhmet Pharmaventures Private Limited are
The primary industry of Sekhmet Pharmaventures Private Limited is Professional, Scientific And Technical.
Sekhmet Pharmaventures Private Limited is unlisted.
The authorized capital of Sekhmet Pharmaventures Private Limited is ₹3,250.00 Cr, and the paid-up capital is ₹2,133.52 Cr.
The compliance status of Sekhmet Pharmaventures Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX